LYTIR

Company · NTHI

NeOnc Technologies Holdings, Inc.

Name as listed on its exchange; filed with the SEC as NEONC TECHNOLOGIES HOLDINGS, INC.

Nasdaq's symbol directory lists NTHI on Nasdaq as “NeOnc Technologies Holdings, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 14 occasions ($723K); insiders sold on 1 occasion ($17K); 1 planned-sale notice; 8 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $723K in total; Insider sales: $17K in total.Apr: Insider purchases $53KAug: Insider purchases $318KSep: Insider purchases $351KSep: Insider sales $17KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $723KInsider sales below: $17K
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. AMIR F. HESHMATPOUR, CEO, President bought on 6 days latest Sep 15, 2026 bought $419K
  2. THOMAS C. CHEN, CEO bought on 7 days latest Sep 14, 2026 bought $303K
  3. KEITHLY GARNETT, CFO sold on 1 day all under a 10b5-1 plan bought on 1 day latest Sep 15, 2026 sold $17K · bought $1K
Every trade (15)
  1. BUYAMIR F. HESHMATPOUR, CEO, President bought Sep 15, 2026 35,000 shares filing $115K
  2. SELLKEITHLY GARNETT, CFO sold Sep 15, 2026 5,000 shares 10b5-1 plan (scheduled) filing $17K
  3. BUYAMIR F. HESHMATPOUR, CEO, President bought Sep 14, 2026 15,000 shares filing $59K
  4. BUYTHOMAS C. CHEN, CEO bought Sep 14, 2026 5,242 shares filing $20K
  5. BUYKEITHLY GARNETT, CFO bought Sep 14, 2026 257 shares filing $1K
  6. BUYAMIR F. HESHMATPOUR, CEO, President bought Sep 11, 2026 37,000 shares filing $136K
  7. BUYTHOMAS C. CHEN, CEO bought Sep 11, 2026 5,556 shares filing $20K
  8. BUYTHOMAS C. CHEN, CEO bought Aug 18, 2026 12,757 shares filing $70K
  9. BUYAMIR F. HESHMATPOUR, CEO, President bought Aug 18, 2026 9,000 shares filing $50K
  10. BUYAMIR F. HESHMATPOUR, CEO, President bought Aug 17, 2026 3,000 shares filing $13K
  11. BUYTHOMAS C. CHEN, Chief Scientific Officer bought Aug 17, 2026 2,472 shares filing $10K
  12. BUYTHOMAS C. CHEN, Chief Scientific Officer bought Aug 14, 2026 33,787 shares filing $130K
  13. BUYAMIR F. HESHMATPOUR, CEO, President bought Aug 14, 2026 12,000 shares filing $45K
  14. BUYTHOMAS C. CHEN, Chief Scientific Officer bought Apr 24, 2026 10,000 shares filing $48K
  15. BUYTHOMAS C. CHEN, Chief Scientific Officer bought Apr 10, 2026 948 shares filing $5K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. KEITHLY GARNETT filed Sep 15, 2026 Officer 5,000 shares planned sale date 09/15/2026 filing $19K

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition; Regulation FD disclosure filing Nov 5, 2026
  2. Regulation FD disclosure filing Nov 3, 2026
  3. Regulation FD disclosure filing Oct 22, 2026
  4. Departure or appointment of directors or officers; Regulation FD disclosure filing Oct 15, 2026
  5. Regulation FD disclosure filing Sep 28, 2026
  6. Material modification to rights of security holders; Amendments to articles or bylaws; change in fiscal year; Regulation FD disclosure filing Sep 21, 2026
  7. Regulation FD disclosure filing Sep 17, 2026
  8. Entry into a material definitive agreement; Regulation FD disclosure filing Sep 10, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.